Drug intelligence / Profile preview

birch pollen

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual
01

Overview

Birch pollen refers to the airborne allergenic particles released by birch trees (genus Betula), which are a major cause of seasonal allergic rhinitis (hay fever) in many regions. Birch pollen is not a pharmaceutical drug but is used as an active ingredient in allergen immunotherapy for individuals with birch pollen allergy. The mechanism of action in immunotherapy involves gradually exposing the immune system to controlled amounts of birch pollen allergens, aiming to induce tolerance and reduce allergic symptoms over time. This can be administered via subcutaneous injections (allergy shots) or sublingual tablets/drops. Birch pollen immunotherapy has been shown to reduce symptoms such as sneezing, nasal congestion, and itchy eyes during the birch pollination season[2][5]. It is also associated with cross-reactivity to other related tree pollens due to homologous proteins.

Other names
Betula pollenbirch tree pollen

Beyond the preview

Go deeper on birch pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on birch pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call